Nephron Pharmaceuticals Appoints Haywood Miller as Interim Chief Executive Officer
Position
Chief Executive Officer
Company
Nephron Pharmaceuticals
Description
Nephron Pharmaceuticals announced the departure of Lou Kennedy from her position as Chief Executive Officer. Haywood Miller has been appointed as the Interim Chief Executive Officer, effective immediately.
Quick answer
Nephron Pharmaceuticals Appoints Haywood Miller as Interim Chief Executive Officer (October 16, 2026). Nephron Pharmaceuticals is based in West Columbia, South Carolina, United States.
- Who is the new Chief Executive Officer at Nephron Pharmaceuticals?
- Nephron Pharmaceuticals named Haywood Miller Chief Executive Officer, announced October 16, 2026.
- What did Nephron Pharmaceuticals announce on October 16, 2026?
- Nephron Pharmaceuticals announced the departure of Lou Kennedy from her position as Chief Executive Officer. Haywood Miller has been appointed as the Interim Chief Executive Officer, effective immediately.
- What does Nephron Pharmaceuticals do?
- Nephron Pharmaceuticals, founded in 1997 by Lou and Bill Kennedy, is a leading provider of generic respiratory and 503B outsourcing medications.
- Where is Nephron Pharmaceuticals based?
- Nephron Pharmaceuticals is based in West Columbia, South Carolina, United States.
- Which similar companies made leadership changes around the same time?
- TORL BioTherapeutics (October 16, 2026), Evotec (October 16, 2026), AL-S Pharma AG (October 14, 2026) and Lupin (October 22, 2026) also announced leadership changes within 45 days of Nephron Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Pharmaceutical and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- TORL BioTherapeutics Appoints Sandip Kapadia as Chief Financial Officer and Eric Sievers, M.D. as Chief Medical Officer (October 16, 2026)
- Evotec Appoints Dr. Joanna Holbrook as Chief Scientific Officer (October 16, 2026)
- AL-S Pharma Appoints Harry Welten as Chief Executive Officer (October 14, 2026)
- Lupin Ltd Appoints Brian Savage as President and Chief Legal Officer (October 22, 2026)
- Retension Pharmaceuticals Appoints Robert Wong as Chief Accounting Officer (October 23, 2026)
- Acadia Pharmaceuticals Announces Departure of Elizabeth H.Z. Thompson, Ph.D. (October 23, 2026)
Who to call at Nephron Pharmaceuticals, and when
A new leader at Nephron Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Nephron Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nephron Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nephron Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nephron Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Nephron Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.